Table 3 Association between demographic, clinical, paraclinical data, and vaccination status with patient mortality

Age

Mean(SD)

61.33(50.49)

57.55(17.57)

0.077**

Sex, N (%)

Male

32 (13.4)

248 (88.6)

0.204*

Female

50 (14.9)

285 (85.1)

BMI, N (%)

< 30

57 (10.4)

368 (86.6)

0.932*

> 30

25 (13.4)

165 (86.6)

Diabetes, N (%)

Yes

58 (30.9)

130 (69.1)

< 0.0001*

No

40 (5.6)

403(64.4)

Hypertension, N (%)

Yes

59(24.3)

184(75.7)

< 0.0001*

No

23(6.2)

349(93.8)

Ischemic heart disease, N (%)

Yes

37 (38.1)

60(61.9)

< 0.0001*

No

45(8.7)

473(91.3)

Dyslipidemia, N (%)

Yes

19 (13.3)

124 (86.7)

0.985*

No

63 (13.3)

409 (86.7)

CKD, N (%)

Yes

11(14.3)

66(85.7)

0.793*

No

71(13.2)

467(86.8)

COPD, N (%)

Yes

5 (19.2)

21 (80.8)

0.366*

No

77 (13.1)

512 (86.9)

Hypothyroidism, N (%)

Yes

7(17.5)

33 (82.5)

0.423*

No

75 (13.0)

500 (87.0)

CVA, N (%)

Yes

4 (36.4)

7 (63.6)

0.023*

No

78 (12.9)

526 (87.1)

Cancer, N (%)

Yes

3(23.1)

10(76.9)

0.296*

No

79 (13.1)

523 (86.9)

Vaccination status, N (%)

complete

10(3)

320(97)

< 0.0001*

incomplete

72(25.3)

213(74.7)

Score of lung involvement at baseline, N (%)

0–8

14 (3.2)

425(96.8)

< 0.0001*

9–16

43(23.9)

101(70.8)

17–25

25(78.1)

7(21.8)

CRP, N (%)

Negative

20(15)

113(85)

0.075*

+

9(7.1)

117(92.9)

++

33(17)

161(83)

+++

20(12.3)

142(87.7)

Intubation, N (%)

Yes

60(89.6)

7(10.4)

< 0.0001*

No

22(4)

526(96)

ICU admission, N (%)

Yes

62(56.4)

48(43.6)

< 0.0001*

No

20(4)

485(96)

Vaccine type, N (%)

Inactive

19(5.6)

322(94.4)

0.633*

viral vector

5(9.6)

47(90.4)

Recombinant proteins

0

3(100)

Recombinant proteins + inactive

0

12(100)

viral vector + inactive

0

4(100)

ESR

51.36(30.92)

45.15(29.66)

0.08**

Mean(SD)

NLR

13.37(8.53)

6.23(5.39)

< 0.0001**

ICU length of stay,y

5.75 (4.23)

4.96 (3.47)

0.30**

hospital length of stay,y

7.91(6.27)

5.30(2.18)

< 0.0001**